Control group:"Scutellaria-Coptis" placebo granules

2 trials

Sponsors

Beijing Chao-Yang Hospital, Capital Medical University

Conditions

Primary Hypertension

Early Phase 1

Coptis Chinensis-Scutellaria for primary hypertension of heart-and-liver fire syndrome: a randomized, double-blind controlled trial

RecruitingChiCTR2000039488

Beijing Chao-Yang Hospital, Capital Medical UniversityPrimary Hypertension

Start: 2020-10-20Updated: 2021-02-01

Coptis Chinensis-Scutellaria for primary hypertension of heart-and-liver fire syndrome: a randomized, double-blind controlled trial

RecruitingITMCTR2100004354

Beijing Chao-Yang Hospital, Capital Medical UniversityPrimary Hypertension

Start: 2020-10-20Updated: 2023-02-20